MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$17,339K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Impairment expenses (see note 2)
Receipt from germfree (see note ...
Proceeds from issuance of loans ...
Others
Negative Cash Flow Breakdown
Net loss
Change in contingent considerati...
Loss (gain) from deconsolidation...
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2024-12-31
Decrease in loan to associate entities
0
Investment in associated company
0
Impact to cash resulting from deconsolidation
0
Purchase of property, plants and equipment
263
Cash acquired from acquisition of octomera (see note 3)
139
Impact to cash resulting from deconsolidation of obi, korea and belgium subsidiaries (see note 20)
11
Investment in long-term deposits
-500
Net cash used in investing activities
365
Proceeds from transaction with redeemable non-controlling interest that do not result in a loss of control
0
Repayment of convertible loans and convertible bonds
0
Proceeds from issuance of shares due to exercise of options and warrants (net of transaction costs)
2,556
Proceeds from issuance of convertible loans
75
Repayment of short and long-term debt
226
Proceeds from issuance of loans payable
6,060
Grant received in respect of third party
774
Receipt from germfree (see note 13f)
6,720
Net cash provided by financing activities
15,959
Impairment of investment (see note 2)
0
Credit loss on convertible loan receivable
0
Net loss
-49,013
Stock-based compensation
3,194
Convertible loans induced conversion expenses
4,304
Capital gain, net
1,580
Depreciation and amortization expenses
2,086
Credit loss net related to obi, korea and belgium subsidiaries
2,049
Effect of exchange differences on inter-company balances
2,447
Net changes in operating leases
-1,588
Change in contingent consideration
-4,643
Interest expense accrued on loans and convertible loans
-1,538
Accounts receivable
-130
Prepaid expenses, other accounts receivable
-2,262
Inventory
-34
Other assets
-43
Related parties, net
2
Accounts payable
-1,279
Accrued expenses and other payable
-820
Employee and related payables
1,300
Deferred taxes, net
2
Impairment expenses (see note 2)
18,338
Share in loss of associated companies, net
-8
Loss (gain) from deconsolidation of obi, korea and belgium subsidiaries in 2024 (octomera in 2023)
4,480
Loss from extinguishment in connection with convertible loan restructuring
-5,422
Net cash used in operating activities
-17,076
Net change in cash and cash equivalents and restricted cash
-752
Net change in cash and cash equivalents and restricted cash
-752
Effect of exchange rate changes on cash and cash equivalents
-40
Cash and cash equivalents and restricted cash at beginning of year
1,479
Cash, cash equivalents and restricted cash at end of year
687
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Receipt from germfree
(see note 13f)
$6,720K
Proceeds from issuance of
loans payable
$6,060K
Proceeds from issuance of
shares due to exercise...
$2,556K
Grant received in
respect of third party
$774K
Investment in long-term
deposits
-$500K
Proceeds from issuance of
convertible loans
$75K
Cash acquired from
acquisition of octomera (see...
$139K
Net change in cash
and cash...
-$752K
Net cash provided by
financing activities
$15,959K
Net cash used in
investing activities
$365K
Canceled cashflow
$226K
Canceled cashflow
$274K
Net change in cash
and cash...
-$752K
Canceled cashflow
$16,324K
Impairment expenses (see
note 2)
$18,338K
Loss from
extinguishment in connection...
-$5,422K
Convertible loans induced
conversion expenses
$4,304K
Stock-based compensation
$3,194K
Effect of exchange
differences on...
$2,447K
Prepaid expenses, other
accounts receivable
-$2,262K
Depreciation and
amortization expenses
$2,086K
Credit loss net related
to obi, korea and...
$2,049K
Net changes in
operating leases
-$1,588K
Interest expense accrued
on loans and...
-$1,538K
Employee and related
payables
$1,300K
Accounts receivable
-$130K
Other assets
-$43K
Inventory
-$34K
Share in loss of
associated companies, net
-$8K
Repayment of short and
long-term debt
$226K
Purchase of property,
plants and equipment
$263K
Impact to cash
resulting from...
$11K
Net cash used in
operating activities
-$17,076K
Canceled cashflow
$44,743K
Net loss
-$49,013K
Change in contingent
consideration
-$4,643K
Loss (gain) from
deconsolidation of obi, korea and...
$4,480K
Capital gain, net
$1,580K
Accounts payable
-$1,279K
Accrued expenses and
other payable
-$820K
Deferred taxes, net
$2K
Related parties, net
$2K
Buy us a coffee
Orgenesis Inc. (ORGS)
Orgenesis Inc. (ORGS)